Instead, parthanatos through hyper-activation of PARP has been induced by chemotherapies in esophageal cancer and glioma cells (Zhao et al. 2015; Ma et al. 2016), suggesting parthanatos as a promising strategy to kill cancer cells. The gene discussed is PARP1; the disease is central nervous system cancer.